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Introduction: While treatment frequency as an indicator of antimicrobial consumption
is often assessed using defined doses, it can also be calculated directly as an Animal
Treatment Index (ATI). In this study, the correlation of calculating antimicrobial usage on
Swiss pig farms using either national Defined Daily Doses (DDDch) or an ATI (number of
treatments per animal per year) and the agreement between the different methods for
the identification of high usage farms were investigated.
Material and Methods: The antimicrobial consumption of 893 Swiss pig herds
was calculated separately for suckling piglets, weaned piglets, fattening pigs, lactating
and gestating sows using the indicators nDDDch (number of DDDch) per animal per
year and ATI. Correlations between the indicators were investigated by calculating
Spearman‘s Rho coefficients. The 5, 10, and 25% highest usage farms were determined
by applying both methods and the interrater reliability was described using Cohen’s
Kappa coefficients and visualized by Bland-Altman plots.
Results: The Spearman‘s Rho coefficients showed strong correlations (r > 0.5) between
nDDDch/animal/year and ATI. The lowest coefficient was shown for the correlation of
both indicators in gestating sows (r = 0.657) and the highest in weaned piglets (r =
0.910). Kappa coefficients identifying high usage farms were the highest in weaned
piglets (k = 0.71, 0.85, and 0.91, respectively for 5, 10, and 25% most frequent users)
and the lowest in gestating sows (k = 0.54, 0.58, and 0.55 for 5, 10, and 25% most
frequent users).
Conclusions: In general, the investigated indicators showed strong correlations and
a broad agreement in terms of the calculated levels of antimicrobial usage and the
identification of high usage farms. Nevertheless, a certain proportion of the farms were
defined differently depending on the indicator used. These differences varied by age
category and were larger in all age categories except weaned piglets when a higher
percentage benchmark was used to define high usage farms. These aspects should
be considered when designing scientific studies or monitoring systems and considering
which indicator to use.
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INTRODUCTION
Antimicrobial resistance poses a threat to both human and
animal health (1). The use of antimicrobials is a key factor in the
development of antimicrobial resistance in human and veterinary
medicine (2, 3). Links between the use of antimicrobials and
an increase or decrease in the frequency of antimicrobial
resistance have already been described in many studies (4–10).
Monitoring systems have been implemented in several countries
as an important measure to investigate and control the use of
antimicrobials on farms (11–15). In Switzerland, the Suissano
Health Programme was developed and launched in 2015 to
monitor antimicrobial usage on pig farms (16).
At the beginning of monitoring antimicrobial usage (AMU),
only sales of antimicrobial products at the wholesale level were
known, so analyses of antimicrobial usage could only be carried
out based on these data. In order to be able to compare
the calculated amounts of active substances between different
populations of farm animals, the European Medicines Agency
(EMA) introduced the so-called “Population Correction Unit
(PCU).” For each animal species, an average value for the weight
at the time of antibiotic treatment is assumed. In this way,
all antibiotic quantities can be standardized with a value in
kilograms of PCU and different animal species can be compared
with each other. However, if the consumption of all antibiotics
is given as a total quantity of active substance, no account is
taken of the fact that the different classes of active substance, for
example penicillins and fluoroquinolones, are used in different
dosages (17). For this reason, other indicators were subsequently
developed to describe the usage of antimicrobials (18, 19). In
human medicine, Defined Daily Doses (DDD) were developed
to analyze the usage of various medicines. In analogy, DDD
have also been published for veterinary medicine (20). These
units describe the daily amount of active ingredient required
for the treatment of an animal with a standardized weight.
Recently, the EMA published guidelines for the development
and publication of indicators for the description of antimicrobial
use in veterinary medicine, but has also made such indicators
available in the form of Defined Daily Doses (DDDvet) and
Defined Course Doses (DCDvet) (21). The DDDvet values based
on data from nine European countries have been shown in some
cases to differ considerably from the dosages specified in the
respective national summaries of product characteristics (SPCs).
Therefore, national DDDs and DCDs have been developed in
several countries (15, 22, 23). For this reason, separate Defined
Daily Doses (DDDch) and Defined Course Doses (DCDch) were
developed for Switzerland, some of which consequently showed
considerable deviations from the indicators published by the
EMA (21, 23–26). Due to these discrepancies, some authors
consider the so-called treatment incidence based on used daily
doses, which describes the proportion of treated animals at
Abbreviations: AMU, antimicrobial usage; AS, active substance; ATI, Animal
Treatment Index; DDDch, Defined Daily Dose Switzerland; DCDch, Defined
Course Dose Switzerland; DDDvet, Defined Daily Dose (EMA); DCDvet, Defined
Course Dose (EMA); EMA, European Medicines Agency; Min, minimum; Max,
maximum; NT, number of treatment days; nDDDch, number of DDDch; SD,
standard deviation; SW, standard weight; VMP, Veterinary Medical Product.
a specific point in time as the method of choice to describe
the usage of antimicrobials (19, 27–30). Moreover, an Animal
Treatment Index (ATI) was introduced, which described the
proportion of treated animals on a farm (31).
The indicators described above are not only used in various
monitoring systems to describe the usage of antimicrobials, but
in most cases can also be used to identify high usage farms by
setting a benchmark, and to determine interventions to lower
AMU (11, 32). In this way a successful reduction of antimicrobial
usage in pig farms could be demonstrated (32, 33). As the
calculation methods sometimes varied considerably, differences
in the identification of high usage farms were also possible: a
recent study by Kasabova et al. (33) presented such differences for
the evaluation of antimicrobial usage in pig and poultry farms in
Germany based on Defined Daily Doses or the Used Daily Doses
(17, 34, 35).
The joint Suissano/Safety+ Health Programme was launched
in 2018 in cooperation of Swiss pig producers, veterinary
authorities, pig trading companies and retailers. The aim of the
programme was to improve transparency concerning AMU. For
participating farms, it is obligatory to record each antimicrobial
treatment of pigs by an electronic treatment journal, which
is run on personal computers or smart phone applications.
All treatments are allocated to five categories (suckling piglets,
weaned piglets, fattening pigs, lactating and gestating sows).
Each participating farm is quarterly provided with a feedback
concerning AMU including a comparison with the AMU levels
of all other participating farms. Although being a voluntary
programme, the number of participating farms increases every
year and by the end of 2020 it is expected that around 2200
farms, or over 50% of all Swiss pig herds will be part of the
programme (Service and competence center of the Swiss pig
industry, SUISAG; personal communication).
In the present study, antimicrobial usage in five different
age categories (suckling piglets, weaned piglets, fattening pigs,
gestating and lactating sows) was calculated for 893 pig herds
participating in the Suissano/Safety+ Health Programme, either
as an ATI or number of DDDch (nDDDch) per animal per year.
Correlations between the two indicators and differences in the
definition of high usage farms were investigated and visualized.
MATERIALS AND METHODS
Data Collection
All farms involved in the study participated in the
Suissano/Safety+ Health Programme in Switzerland. Farmers
recorded their antimicrobial usage using electronic treatment
journals which were linked to a central database from which
all data used in this study were retrieved. For each individual
treatment, in addition to the antimicrobial product used and the
amount administered, the number of animals treated and the
duration of the treatment were recorded. Each treatment was
assigned to an age category (suckling piglets, weaned piglets,
fattening pigs, gestating sows, and lactating sows). In addition,
the numbers of suckling piglets, weaned piglets and fattening
pigs produced from all the herds participating in this study once
a year had to be reported by the farmer and were registered in the
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TABLE 1 | Number of farms out of the 893 study farms providing complete
datasets of AMU for each age category; minimum (min), median, maximum (max),






Animals housed or produced
Median Min Max
Lactating sows 462 12,176 22 5 140
Gestating sows 319 30,522 75 14 536
Suckling piglets 404 1,081,410 2,200 180 16,500
Weaned piglets 360 878,154 2,000 100 15,000
Fattening pigs 531 713,661 1,050 30 8,000
electronic treatment journal, as well as the number of gestating
and lactating sows housed on the study farms.
A total of 893 farms provided data for our study. Three
hundred and ninety-nine were fattening farms providing
data concerning fattening pigs and 481 were breeding farms
(housing sows, suckling piglets, and weaned piglets), of
which 190 were connected to a sow pool system (housing
lactating sows, suckling piglets and weaned piglets or only
gestating sows). Thirteen farms kept both weaned piglets and
fattening pigs. Two hundred and seventy-seven of the 481
breeding farms also kept at least 30 fattening pigs (farrow-
finish farms) and thus provided data concerning all age
categories (Table 1).
For each age category, data were only included in the
dataset if they had been recorded continuously for the study
period. The second inclusion criteria meant that data must
be entered in the electronic treatment journal no later than
7 days after application, according to the requirements of the
Suissano/Safety+Health Programme.
The total amount of each active substance, administered
during the study period (1 year) was added up and divided by
the corresponding DDDch value defined by Echtermann et al.
(24) multiplied by the standard weight of the corresponding
animal group (suckling piglets: 4 kg; weaned piglets: 12 kg;
fattening pigs: 50 kg; sows: 220 kg) (36). This calculation was
performed separately for each active substance used and then
the calculated nDDDch of all active substances used in each
age category were summed up. The results for nDDDch
were divided by the number of animals kept (sows) or
produced (suckling piglets, weaned piglets, fattening pigs) during
the study period (1. October 2018 to 30. September 2019).
The nDDDch/animal/year was calculated according to the
following formula.
∑










∗ number of animals housed per year
= nDDDch/animal/year
The ATI was calculated for each active substance and age category
by adding up all treatments performed (number of treatments,
NT) and dividing the sum by the number of animals kept or
produced during the study period. One treatment was equivalent
to one application per animal per day. If, for example, 20 animals
were treated on 3 days during a therapy, this corresponded to
60 treatments. For treatments with products containing several
antimicrobial agents, each agent was individually evaluated as
a treatment.
For treatments with long-acting products, multiplying factors
corresponding to the duration of the pharmaceutical activity
were used to adjust the treatment duration. However, since
these factors only served to compare the usage of antimicrobial
ingredients with different pharmaceutical activity, it had no
influence on the comparison of the two calculation methods
and was disregarded in this study. Recorded treatments that
could be clearly identified as incorrect, due to markedly
differing numbers of animals, treatment duration or quantities
of Veterinary Medical Products (VMPs), were removed from
the analysis.
Statistical Analyses
All datasets were prepared with Microsoft Excel R© Version 16.30.
Statistical analysis was carried out using IBM SPSS R© Version 25.
All datasets were tested for normal distribution by Shapiro-Wilk
test. For not normally distributed datasets, correlations between
the indicators were investigated by calculating Spearman’s Rho
coefficients. Further, the relationship between both indicators
was visualized by scatterplots and by linear regression lines
using a generalized linear model for the age categories with
the lowest and the highest Spearman‘s Rho coefficients. The
interrater reliability between the tested calculation methods
for identifying the 5, 10, and 25% highest usage farms was
described using Cohen’s Kappa coefficients and visualized
by Bland-Altman plots of means and differences between
ATI and nDDDch/animal/year. Values of ±1.96 multiplied
with the standard deviation of the differences mentioned
were defined as outliers. The percentage of farms for which
agreement could be found when determining frequent users
by either nDDDch/animal/year or ATI was calculated for each
age category.
RESULTS
Tables 2–6 give an overview of the antimicrobial classes used
in the study farms in the different age categories. A total
AMU of 649,290 treatments, respectively, 557,830 DDDch was
calculated for the study period. This represents a deviation
of 14%, when calculating NT or nDDDch, respectively. For
the different classes of active substances, strongly deviating
agreement of the indicators could be observed: While the
results for the usage of sulfonamides in lactating sows were
almost identical when calculated with both indicators, the
NT with tetracyclines in weaning piglets was almost three
times higher than the nDDDch and on the other hand, the
nDDDch for treatments with aminoglycosides was 2.5 times
higher than the NT. Table 7 shows the correlation between
the calculations of the AMU as ATI or nDDDch/animal/year
and the agreement of the definition of 5, 10, and 25% high
usage farms, depending on the method chosen. The highest
correlation coefficients between both indicators could be found
for lactating sows and weaned piglets and the lowest for
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TABLE 2 | Total, minimum (min), median, maximum (max), 10% (0.1), 25% (0.25), 75% (0.75), 90% (0.9) percentiles and standard deviation (SD) of AMU in suckling
piglets of the study farms measured using the indicators NT, ATI, nDDDch, and nDDDch/animal/year (nDDDch/a/y) displayed by active substance (AS).
Suckling piglets
AS Indicator Total Min 0.10 0.25 Median 0.75 0.90 Max SD
Polypeptides NT 11,095 0.00 0.00 0.00 0.00 0.00 52 2,184 140
ATI 0.06 0.00 0.00 0.00 0.00 0.00 0.02 0.26 0.03
nDDDch 6,508 0.00 0.00 0.00 0.00 0.00 29 1,051 82
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.39 0.03
Cephalosporines NT 38 0.00 0.00 0.00 0.00 0.00 0.00 38 1.89
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.03 0.00
nDDDch 15 0.00 0.00 0.00 0.00 0.00 0.00 15 0.75
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Penicillins NT 85,868 0.00 0.00 6 36 150 506 5,429 524
ATI 0.08 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
nDDDch 69,295 0.00 0.00 1.12 19 144 488 5,263 467
nDDDch/a/y 0.06 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fluoroquinolones NT 6,453 0.00 0.00 0.00 0.00 0.00 37 678 61
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.31 0.02
nDDDch 9,600 0.00 0.00 0.00 0.00 0.00 29 1,520 123
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.65 0.05
Aminoglycosides NT 13,524 0.00 0.00 0.00 0.00 1.00 62 1,574 142
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.03 0.33 0.03
nDDDch 31,598 0.00 0.00 0.00 0.00 0.72 148 3,921 343
nDDDch/a/y 0.03 0.00 0.00 0.00 0.00 0.00 0.05 1.19 0.09
Macrolides NT 243 0.00 0.00 0.00 0.00 0.00 0.00 120 7.09
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.17 0.01
nDDDch 244 0.00 0.00 0.00 0.00 0.00 0.00 104 7.31
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.01
Tetracyclines NT 11,973 0.00 0.00 0.00 0.00 0.00 60 1,760 144
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.03 0.54 0.05
nDDDch 8,332 0.00 0.00 0.00 0.00 0.00 39 1,329 98
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.47 0.04
Trimethoprim NT 4,202 0.00 0.00 0.00 0.00 0.00 16 490 45
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.22 0.02
nDDDch 6,241 0.00 0.00 0.00 0.00 0.00 15 884 76
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.24 0.03
Sulfonamides NT 4,445 0.00 0.00 0.00 0.00 0.00 20 490 45
ATI 0.00411 0.00 0.00 0.00 0.00 0.00 0.01 0.22 0.02
nDDDch 6,483 0.00 0.00 0.00 0.00 0.00 18 884 76
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.24 0.03
Total NT 137,841 1.00 24 45 144 352 938 5,934 677
ATI 0.13 0.00 0.01 0.02 0.07 0.15 0.27 1.50 0.15
nDDDch 138,316 0.24 20 32 125 378 887 6,042 722
nDDDch/a/y 0.13 0.00 0.01 0.02 0.06 0.16 0.35 1.83 0.19
gestating sows and fattening pigs. Both agreement (a) and
the interrater reliability (Kappa coefficient) of the investigated
indicators were higher when identifying the 5 and 10% high
usage farms, compared to the identified 25% high usage farms
(Table 7). Exception were the weaned piglets, where Kappa
coefficient became higher when larger proportions of farms
were identified as high users. Generally, weaned piglets showed
the best agreement (≥96%) irrespective of the percentage of
high usage farms identified and the best correlation between
the indicators.
The correlation between both methods is further
demonstrated with the data from weaned piglets as the
age category with the best correlation between both
indicators and with gestating sows, where the lowest
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TABLE 3 | Total, minimum (min), median, maximum (max), 10% (0.1), 25% (0.25), 75% (0.75), 90% (0.9) percentiles and standard deviation (SD) of AMU in weaned
piglets of the study farms measured using the indicators NT, ATI, nDDDch, and nDDDch/animal/year (nDDDch/a/y) displayed by active substance (AS).
Weaned piglets
AS Indicator Total Min 0.10 0.25 Median 0.75 0.90 Max SD
Polypeptides NT 116,729 1.00 102 270. 740. 1,800 3,060 21,340 2,986
ATI 0.13 0.00 0.00 0.00 0.00 0.00 0.40 2.40 0.38
nDDDch 102,472 0.10 85 192 668 1,653 2,974 14,503 2,412
nDDDch/a/y 0.12 0.00 0.00 0.00 0.00 0.00 0.31 0.35
Cephalosporines NT 3 3.00 3.00 3.00 3.00 3.00 3.00 3.00 –
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
nDDDch 6.25 6.25 6.25 6.25 6.25 6.25 6.25 6.25 –
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Penicillins NT 51,621 0.00 0.00 0.00 9.00 40 205 10,619 717
ATI 0.06 0.00 0.00 0.00 0.00 0.02 0.07 1.76 0.17
nDDDch 52,086 0.00 0.00 0.00 3.33 40 196 10,700 718
nDDDch/a/y 0.06 0.00 0.00 0.00 0.00 0.02 0.08 1.89 0.17
Fluoroquinolones NT 2,487 1.00 2.00 4.00 12 39 253 717 157
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.42 0.02
nDDDch 3,626 0.42 2.11 5.00 13 33 236 1,296 268
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.42 0.03
Aminoglycosides NT 2,550 1.00 3.00 4.75 11 46 81 37 6
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.11 0.01
nDDDch 4,250 1.25 2.72 6.67 22 77 152 534 94
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.11 0.01
Macrolides NT 28,938 10 38 85 231 460 872 12,030 1,770
ATI 0.03 0.00 0.00 0.00 0.00 0.00 0.03 2.51 0.18
nDDDch 24,993 23 46 11 233 497 815 8,495 1,244
nDDDch/a/y 0.03 0.00 0.00 0.00 0.00 0.00 0.04 1.77 0.15
Tetracyclines NT 98,860 1.00 5.00 18 71 429 1,480 21,340 2,914
ATI 0.11 0.00 0.00 0.00 0.00 0.01 0.16 2.96 0.31
nDDDch 40,316 0.20 4.64 11 45 320 798 8,495 928
nDDDch/a/y 0.05 0.00 0.00 0.00 0.00 0.00 0.09 1.77 0.18
Trimethoprim NT 11,313 1.00 2.30 8.75 30 139 359 3,652 486
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.73 0.06
nDDDch 23,306 1.17 3.31 8.00 332 161 371 3,347 465
nDDDch/a/y 0.03 0.00 0.00 0.00 0.00 0.00 0.01 1.19 0.09
Sulfonnamides NT 46,981 0.00 0.00 0.00 0.00 5.75 211 12,030 789
ATI 0.05 0.00 0.00 0.00 0.00 0.00 0.11 2.51 0.21
nDDDch 65,870 0.00 0.00 0.00 0.00 6.84 206 8,084 605
nDDDch/a/y 0.08 0.00 0.00 0.00 0.00 0.00 0.11 1.96 0.21
Pleuromutilins NT 8,104 6.00 164 400 1,269 1,671 2,869 3,667 1,429
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.76 0.06
nDDDch 7,014 4.00 93 225 879.00 2,136 3,770 4,860 1,991
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.00 1.01 0.06
Total NT 367,586 1.00 4.00 20 98.00 590 2,135 42,842 3,741
ATI 0.31 0.00 0.00 0.01 0.04 0.29 1.12 7.52 0.81
nDDDch 300,168 0.10 3.58 15 91 642 1,933 25,076 2,209
nDDDch/a/y 0.34 0.00 0.00 0.01 0.06 0.27 0.97 17 0.67
correlation was found (Figures 1, 2). The interrater
reliability is visualized by Bland-Altman plots for these
age categories (Figures 3, 4). Bland Altman plots of
weaned piglets showed five out of 360 (2%) to be outliers,
while in gestating sows this was shown to be 13 out of
319 (4%).
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TABLE 4 | Total, minimum (min), median, maximum (max), 10% (0.1), 25% (0.25), 75% (0.75), 90% (0.9) percentiles and standard deviation (SD) of AMU in fattening pigs
of the study farms measured using the indicators NT, ATI, nDDDch and nDDDch/animal/year (nDDDch/a/y) displayed by active substance (AS).
Fattening pigs
AS Indicator Total Min 0.10 0.25 Median 0.75 0.90 Max SD
Cephalosporines NT 9 2.00 2.20 2.50 3.00 3.50 3.80 4.00 1.00
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
nDDDch 16 3.75 4.00 4.38 5.00 6.00 6.60 7.00 1.64
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00
Penicillins NT 45,976 0.00 2.00 5.00 16 48 134 7,622 416
ATI 0.06 0.00 0.00 0.01 0.02 0.05 0.10 2.72 0.22
nDDDch 39,141 0.00 0.08 0.98 7.20 40 120 7,965 425
nDDDch/a/y 0.05 0.00 0.00 0.00 0.01 0.04 0.11 3.19 0.24
Fluoroquinolone NT 144 1.00 1.20 3.00 3.50 17 36 44 15
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.00
nDDDch 160 0.70 1.92 3.15 7.00 21 30 39 13
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.01
Aminoglycosides NT 1,524 1.00 1.80 3.00 6.00 18 42 96 20
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.14 0.01
nDDDch 1,919 0.56 1.56 3.00 8.70 22 53 223 31
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.15 0.01
Macrolides NT 11,919 3.00 3.00 7.00 95 811 1,685 7,000 1,859
ATI 0.02 0.00 0.00 0.00 0.00 0.00 0.00 2.80 0.16
nDDDch 12,296 0.20 1.23 7.05 73 449 1,680 8,330 2,219
nDDDch/a/y 0.02 0.00 0.00 0.00 0.00 0.00 0.00 3.33 0.16
Tetracyclines NT 25,152 1.00 2.00 4.00 10.00 37 224 7,000 879
ATI 0.04 0.00 0.00 0.00 0.00 0.00 0.01 2.80 0.21
nDDDch 20,633 0.20 1.20 2.42 8.90 18 94 8,330 910
nDDDch/a/y 0.03 0.00 0.00 0.00 0.00 0.00 0.01 3.33 0.19
Trimethoprim NT 8,966 1.00 1.70 2.75 6.00 183 493 6,000 1,133
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.00 4.00 0.23
nDDDch 5,308 0.70 1.74 3.08 6.13 106 363 3,199 606
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.00 2.13 0.13
Sulfonamides NT 29,324 0.00 0.00 0.00 0.00 0.00 0.00 12,000 622.20
ATI 0.04 0.00 0.00 0.00 0.00 0.00 0.00 8.00 0.49
nDDDch 22,343 0.00 0.00 0.00 0.00 0.00 0.00 8,330 473
nDDDch/a/y 0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.31
Pleuromutilines NT 2,264 1.44 3.02 4.76 15 38 388 1,333 368
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 0.02
nDDDch 2,068 2.00 3.00 6.25 18 62 723 1,000 356
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.65 0.03
Total NT 125,278 1.00 3.00 8.00 24 75 236 25,000 1,455
ATI 0.18 0.00 0.00 0.01 0.03 0.06 0.15 12.05 0.91
nDDDch 103,884 0.05 1.20 3.62 16 62 178 32,955 1,558
nDDDch/a/y 0.15 0.00 0.00 0.00 0.02 0.05 0.15 13 0.75
DISCUSSION
In the present study we were able to assess the correlation of
the indicators nDDDch/animal/year and ATI when measuring
AMU on pig farms and the agreement in the definition of high
usage farms. The number of treatment days NT and nDDDch
calculated for the study farms showed marked differences
for some active substances, while for others the results were
similar. The degree of agreement between the two indicators
was therefore most likely dependent on which antimicrobial
substances were used in an age category.
The Spearman’s Rho coefficients for correlations between
the indicators ATI and nDDDch/animal/year observed were
statistically determined as moderate (>0.6) for fattening pigs
and gestating sows and as strong or very strong (>0.7) for
suckling piglets, weaned piglets and lactating sows (37). The
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TABLE 5 | Total, minimum (min), median, maximum (max), 10% (0.1), 25% (0.25), 75% (0.75), 90% (0.9) percentiles and standard deviation (SD) of AMU in lactating sows
of the study farms measured using the indicators NT, ATI, nDDDch and nDDDch/animal/year (nDDDch/a/y) displayed by active substance (AS).
Lactating sows
AS Indicator Total Min 0.10 0.25 Median 0.75 0.90 Max SD
Cephalosporines NT 21 0.00 0.00 0.00 0.00 0.00 0.00 10 0.63
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.03
nDDDch 17 0.00 0.00 0.00 0.00 0.00 0.00 7.91 0.50
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.40 0.03
Penicillins NT 3,212 0.00 0.00 0.00 2.00 8.00 15 244 17
ATI 0.26 0.00 0.00 0.00 0.09 0.30 0.66 6.35 0.56
nDDDch 2,528 0.00 0.00 0.00 0.28 4.55 12 295 19
nDDDch/a/y 0.21 0.00 0.00 0.00 0.01 0.18 0.50 6.85 0.63
Fluoroquinolone NT 271 0.00 0.00 0.00 0.00 0.00 1.00 31 2.44
ATI 0.02 0.00 0.00 0.00 0.00 0.00 0.05 0.97 0.10
nDDDch 291 0.00 0.00 0.00 0.00 0.00 1.61 32 2.63
nDDDch/a/y 0.02 0.00 0.00 0.00 0.00 0.00 0.06 1.02 0.11
Aminoglycosides NT 1,587 0.00 0.00 0.00 0.00 2.00 11 204 12
ATI 0.13 0.00 0.00 0.00 0.00 0.10 0.41 10 0.55
nDDDch 1,573 0.00 0.00 0.00 0.00 2.27 10 189 11
nDDDch/a/y 0.13 0.00 0.00 0.00 0.00 0.10 0.42 9.46 0.53
Macrolides NT 8 0.00 0.00 0.00 0.00 0.00 0.00 7.00 0.33
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.26 0.01
nDDDch 12 0.00 0.00 0.00 0.00 0.00 0.00 12 0.55
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.44 0.02
Tetracyclines NT 347 0.00 0.00 0.00 0.00 0.00 0.00 88 5.26
ATI 0.03 0.00 0.00 0.00 0.00 0.00 0.00 1.83 0.15
nDDDch 244 0.00 0.00 0.00 0.00 0.00 0.00 80 4.31
nDDDch/a/y 0.02 0.00 0.00 0.00 0.00 0.00 0.00 1.67 0.12
Trimethoprim NT 2,251 0.00 0.00 0.00 2.00 6.00 14.00 92.00 8.31
ATI 0.18 0.00 0.00 0.00 0.08 0.29 0.56 2.92 0.32
nDDDch 2,222 0.00 0.00 0.00 1.61 6.75 13.96 64.36 7.91
nDDDch/a/y 0.18 0.00 0.00 0.00 0.08 0.29 0.51 2.65 0.34
Sulfonamides NT 2,262 0.00 0.00 0.00 2.00 6.00 14.00 92.00 8.31
ATI 0.19 0.00 0.00 0.00 0.08 0.29 0.56 2.92 0.32
nDDDch 2,237 0.00 0.00 0.00 1.64 6.80 13.96 64.36 7.92
nDDDch/a/y 0.18 0.00 0.00 0.00 0.08 0.30 0.51 2.65 0.34
Total NT 9,959 1.00 3.00 6.00 13 25 44 331 32
ATI 0.82 0.04 0.15 0.29 0.59 1.00 1.85 16.55 1.13
nDDDch 9,124.00 0.05 2.27 4.78 11 25 41.73 390 30
nDDDch/a/y 0.75 0.00 0.11 0.23 0.53 0.98 1.77 15 1.14
Kappa coefficient demonstrated a substantial agreement (>0.6)
when defining 5% high usage farms for all age categories, except
gestating sows. If defining 10 and 25% high usage farms, a
moderate (>0.4) to substantial agreement was shown for all age
categories except weaned piglets, where very good agreement
(>0.8) could be shown (38).
The agreement of both indicators concerning the
identification of high usage farms generally was the better,
the smaller the percentage of farms was determined as high
usage farms. If only 5% of the farms were determined as high
users, even in age categories showing lower Kappa coefficient
and lower correlations between both indicators, such as gestating
sows or fattening pigs, more than 95% of the high usage farms
were identified in agreement of both indicators. When 25%
of the farms were determined as high users, the agreement
between both indicators decreased to 75 and 77% in fattening
pigs and gestating sows, respectively, due to the lower correlation
and Kappa coefficient, while in weaned piglets with the best
correlation and highest Kappa coefficient, the agreement still
was 96%.
A final statement on whether the agreement between two
indicators is sufficient or not cannot be made. Since only the
degree of agreement can be shown, an extensive discussion is
necessary to precisely evaluate which indicator is more suitable
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TABLE 6 | Total, minimum (min), median, maximum (max), 10% (0.1), 25% (0.25), 75% (0.75), 90% (0.9) percentiles and standard deviation (SD) of AMU in gestating
sows of the study farms measured using the indicators NT, ATI, nDDDch and nDDDch/animal/year (nDDDch/a/y) displayed by active substance (AS).
Gestating sows
AS Indicator Total Min 0.10 0.25 Median 0.75 0.90 Max SD
Cephalosporines NT 74 0.00 0.00 0.00 0.00 0.00 0.00 30 2.13
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.02
nDDDch 76 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Penicillins NT 6,908 0.00 1.00 4.00 9.00 20 46 540 47
ATI 0.23 0.00 0.02 0.05 0.11 0.28 0.50 6.02 0.50
nDDDch 4,438 0.00 0.07 0.57 3.55 12 30 650 46
nDDDch/a/y 0.15 0.00 0.00 0.01 0.05 0.15 0.33 6.50 0.47
Fluoroquinolones NT 55 0.00 0.00 0.00 0.00 0.00 0.00 16 1.31
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.27 0.02
nDDDch 68 0.00 0.00 0.00 0.00 0.00 0.00 26 1.79
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.44 0.03
Aminoglycosides NT 724 0.00 0.00 0.00 0.00 0.00 5.00 88 8.38
ATI 0.02 0.00 0.00 0.00 0.00 0.00 0.09 0.73 0.08
nDDDch 634 0.00 0.00 0.00 0.00 0.00 4.53 91 7.60
nDDDch/a/y 0.02 0.00 0.00 0.00 0.00 0.00 0.07 0.58 0.07
Macrolides NT 29 0.00 0.00 0.00 0.00 0.00 0.00 18 1.08
ATI 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.13 0.01
nDDDch 32 0.00 0.00 0.00 0.00 0.00 0.00 25 1.41
nDDDch/a/y 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.18 0.01
Tetracyclines NT 381 0.00 0.00 0.00 0.00 0.00 0.20 93 6.62
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.07
nDDDch 155 0.00 0.00 0.00 0.00 0.00 0.00 27 2.62
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.25 0.03
Trimethoprim NT 221 0.00 0.00 0.00 0.00 0.00 1.00 25 2.74
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.34 0.03
nDDDch 228 0.00 0.00 0.00 0.00 0.00 1.39 29 2.97
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.39 0.04
Sulfonamides NT 234 0.00 0.00 0.00 0.00 0.00 1.20 25 2.90
ATI 0.01 0.00 0.00 0.00 0.00 0.00 0.02 0.34 0.03
nDDDch 243 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
nDDDch/a/y 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total NT 8,626 1.00 3.00 6.00 12.00 27 65 548 51
ATI 0.28 0.01 0.04 0.08 0.17 0.37 0.64 6.32 0.54
nDDDch 5,873 0.02 0.87 2.73 6.67 18 340 660 49
nDDDch/a/y 0.19 0.00 0.01 0.03 0.10 0.23 0.49 6.60 0.51
when planning a scientific study or when establishing and
implementing a monitoring system for which a benchmark
should be set (39).
Since the DDDch have been defined on the basis of SPCs in
Switzerland, in order to achieve a good agreement between the
indicators it is necessary that antimicrobial treatments are carried
out as closely as possible to the recommendations found in the
SPCs. Any change in dosage leads to a change in the number
of DDD, but not in the number of treatments. According to
our analyses, for some substances, significantly different levels
of DDDch and ATI were calculated per age category. This
result is probably due to the effect described above and is also
responsible for both the outlier shown in our Bland-Altman Plots
and decreased agreement when identifying high usage farms. On
the other hand, the simultaneous calculation of both indicators
may contribute to a mutual plausibility check of the results
by, for example, identifying incorrect entries into the electronic
treatment journal.
The divergent agreement between the indicators when
comparing the different age categories could also be due to
different indications, treatment patterns and antimicrobials used.
For example, gestating sows often are suffering from lameness
compared to weaned piglets which are more frequently affected
by diarrhea. Further research is needed on this issue. Also, if
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TABLE 7 | Agreement (a) in percent when defining 5, 10, and 25% high usage farms by calculating AMU with either ATI or nDDDch/animal/year for five age categories
(fattening pigs, weaned piglets, suckling piglets, lactating and gestating sows), interrater reliability between both indicators expressed as Kappa coefficient (k) and
correlation between both indicators displayed using Spearman‘s Rho (r) coefficients.
5% High usage 10% High usage 25% High usage Correlation
a k a k a k r
Fattening pigs 98% 0.844 93% 0.671 75% 0.510 0.673
Weaned piglets 97% 0.708 97% 0.846 96% 0.911 0.910
Suckling piglets 96% 0.643 91% 0.528 77% 0.554 0.793
Lactating sows 96% 0.634 96% 0.771 88% 0.77 0.889
Gestating sows 95% 0.539 92% 0.583 77% 0.553 0.657
FIGURE 1 | Scatterplots and linear regression of AMU calculated either as Animal Treatment Index (ATI) or the number of DDDch/animal/year (nDDDch/animal/year)
for weaned piglets from 360 study farms.
actual weights at treatment deviate from the standard weights
used for the calculation of DDDch, it may contribute to
differences between DDDch and ATI. While, for example, a
rather uniform weight during treatment can be expected for sows
particularly in the case of suckling pigs, stronger deviations can
be assumed between a newly born piglet with an average weight
of 1.2 kg compared to a 4-week-old piglet with a multiple of
this weight.
Differences between the indicators for AMU have been shown
before (25, 34, 40). An increasing number of monitoring systems
are being established worldwide, however, the harmonization of
the measurement of usage has so far been less advanced (17).
While in some countries the evaluation of antimicrobial usage is
based on DDDs, an ATI or comparable methods are also used in
other countries, including Switzerland (14, 15).
Treatment frequency calculations based on DDD are only
an estimate of AMU on farms because they are calculated
using standardized weights and doses. This indicator may be
more appropriate if it is difficult to obtain precise information
concerning the AMU, especially the number of treatments, the
dosage used, and the weight of the treated animals. However,
if this information can be collected reliably and accurately, the
calculation of an ATI or treatment frequency based on used daily
doses is feasible (27). On the other hand, it must also be taken
into account that development of bacterial resistance also occurs
outside the animal by excreted metabolites after antimicrobial
therapy. In this situation, the quantities of antimicrobials used on
a farm should also be taken into account (41, 42). These can be
derived more reliably from DDDs, where standard weights and
dosages are used and thus standardized antimicrobial quantities.
To calculate the quantities of active substances used from an ATI,
further information on the weight of the treated animals and the
dosage applied is necessary.
In the present study it could be shown that despite
the generally good agreement between the two indicators, a
considerable proportion of the farms were nevertheless rated
differently as high usage farms depending on the indicator used.
In Switzerland, different monitoring systems are concurrently
measuring AMU on farms. The use of different indicators may
cause a considerable lack of compliance by farm managers when
farm rating varies depending on the monitoring system used and
may adversely affect the acceptance of such programmes.
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FIGURE 2 | Scatterplots and linear regression of AMU calculated either as Animal Treatment Index (ATI) or the number of DDDch/animal/year (nDDDch/animal/year)
for gestating sows from 319 study farms.
FIGURE 3 | Bland-Altman Plots visualizing interrater reliability of the indicators Animal Treatment Index (ATI) and number of DDDch (nDDDch)/animal/year for 360
farms housing weaned piglets. X-Axis: means of ATI and nDDDch/animal/year; Y-axis: differences between ATI and nDDDch/animal/year. Red lines: ±1.96 * standard
deviation of the datasets calculated from the differences between ATI and nDDDch/animal/year.
Although many discussions are taking place regarding the
comparability of different indicators, other factors should be
taken into account which also influence the calculation of
AMU: different data sources and deviating values provided,
e.g., concerning the kept animals, may also result in different
outcomes. In Switzerland, the numbers of animals reported to
the veterinary authorities are in some cases significantly different
from those used by the on-farm reproduction software, which is
used as a data source for the number of animals on the farms (43).
Our earlier investigations have shown that within the
Suissano/Safety+ Health Programme significant changes in the
usage of antimicrobials could be achieved by only measuring and
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FIGURE 4 | Bland-Altman Plots visualizing interrater reliability of the indicator Animal Treatment Index (ATI) and number of DDDch (nDDDch)/animal/year for 319 farms
housing gestating sows. X-Axis: mean of ATI and nDDDch/animal/year; Y-axis: differences between ATI and nDDDch/animal/year. Red lines: ±1.96 * standard
deviation of the datasets calculated from the differences between ATI and nDDDch/animal/year.
communicating levels of antimicrobial usage, without defining
a benchmark (44). Thus, if a benchmark is not necessarily
needed and the good correlation of both indicators found in
the present study is taken into consideration, it may be of
secondary importance which indicator to choose for the aim of
reducing AMU.
It is also important to point out that irrespective of the
method of calculation, a long-term reduction in the usage of
antimicrobials while respecting animal health standards can only
be feasibly achieved through close collaboration with veterinary
professionals. Improving biosecurity as well as animal health
e.g., by introducing vaccination protocols, has a positive impact
on AMU (45). Ideally, any AMU monitoring programme will
intensify veterinary advice and ensure a reduced AMU without
impairing animal health rather than rating farms based only on
their antimicrobial usage.
CONCLUSIONS
In the present study, strong correlations and a broad agreement
in identifying high usage farms could be demonstrated for
the indicators nDDDch/animal/year and ATI. Nevertheless,
depending on the indicator used a considerable proportion of the
study farms were assessed differently. These differences varied
by age category and were larger with a higher proportion of
farms determined as high usage farms. These aspects have to
be considered when designing scientific studies or monitoring
systems and when deciding on which indicator to use.
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